is compounded semaglutide going away The Shortage Ending: What's Next For Drugs? Woman shares journey of weight

Peptide clearance depends on: Half-life (short vs long-acting compounds) Route of administration (subcutaneous vs intramuscular) Structural modifications (e.g., PEGylation or DAC binding) Metabolic rate and enzymatic activity Short-acting peptides like GHRP-6, Ipamorelin, and Tesamorelin are typically cleared within 2448 hours

In fact, theres been an influx of people reporting just that, as a recent Vox article explored

The pooled outcomes for tirzepatide showed a more significant positive impact in each individual lipid measure as compared to semaglutide in a population with similar baseline characteristics

The decision often comes down to how you weigh regulatory status, access considerations, and maximum efficacy against each other